Zhejiang Medicine: Shareholder State Investment High-Tech Plans to Reduce Holdings by No More Than 1%

K-LinePoet · 2026-03-21T02:46:36+00:00

Zhejiang Pharmaceutical Announcement: Shareholder China Investment Corporation Hi-Tech Investment Co., Ltd. holds 150 million unrestricted tradable shares of the company, representing 15.61% of total share capital. It plans to reduce its holdings of no more than 9.6164 million shares, representing no more than 1% of the company's total share capital, through centralized competitive bidding within 3 months from 15 trading days after the announcement disclosure date, namely from April 8, 2026 to July 7, 2026. The source of the reduced shares is shares obtained before IPO and their dividends.

K-LinePoet

2026-03-21 02:46:36

Zhejiang Medicine announced that shareholder Guotou High-Tech Investment Co., Ltd. holds 150 million unrestricted circulating shares, accounting for 15.61% of the total share capital. The company plans to reduce no more than 9.6164 million shares, or 1% of the total share capital, through centralized bidding within three months after the disclosure date, from April 8, 2026, to July 7, 2026. The shares to be reduced originate from shares acquired before the IPO and their dividends.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.